Regencell Bioscience Holdings Ltd (RGC)
32.84 +8.54 (+35.14%) 11:44 ET [NASDAQ]
32.38 x 100 33.20 x 1
Realtime by (Cboe BZX)
32.38 x 100 33.20 x 1
Realtime 24.01 -0.29 (-1.19%) 09:16 ET
for Fri, Apr 4th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
| Operating Expenses | 4,737 | 6,274 | 7,618 | 1,381 | 812 |
| Operating Income | -4,737 | -6,274 | -7,618 | -1,381 | -812 |
| Other Income | 374 | 211 | 23 | 35 | 0 |
| Pre-tax Income | -4,363 | -6,062 | -7,595 | -1,347 | -812 |
| Net Income Continuous | -4,363 | -6,062 | -7,595 | -1,347 | -812 |
| Minority Interests | -61 | -191 | -149 | N/A | N/A |
| Net Income | $-4,302 | $-5,871 | $-7,446 | $-1,347 | $-812 |
| EPS Basic Total Ops | -0.33 | -0.45 | -0.58 | -0.13 | -0.08 |
| EPS Basic Continuous Ops | -0.34 | -0.47 | -0.59 | -0.13 | -0.08 |
| EPS Diluted Total Ops | -0.33 | -0.45 | -0.58 | -0.13 | -0.08 |
| EPS Diluted Continuous Ops | -0.34 | -0.47 | -0.59 | -0.13 | -0.08 |
| EPS Diluted Before Non-Recurring Items | -0.33 | -0.45 | -0.58 | N/A | N/A |
| EBITDA(a) | $-4,431 | $-5,981 | $-7,468 | $-1,355 | $-803 |